Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.
- 2025-05-12
- RCT
- Frontiers in immunology 16
- Samira Rastgoo
- Katayoun Pourvali
- Seyed Ahmad Raeissadat
- Ghazaleh Eslamian
- Hamid Zand
- PubMed: 40421021
- DOI: 10.3389/fimmu.2025.1570441
- High evidence
- Clinical
co-administration of NAC with 1000 IU of Vit-D significantly downregulated p16 transcripts in PBMCs compared to Vit-D 1000 IU alone.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 600 mg daily